Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

Press Releases 2006

French development agency AFD commits €1.5m to DNDi for the development of two news drugs for malaria
[ Paris, Geneva - June 14, 2006 ]
AFD (Agence Française de Développement) and DNDi (Drugs for Neglected Diseases initiative) finalised a partnership agreement today to support the development of two new drugs for malaria. [Français]

More

Waking Up Governments for Research on Neglected Diseases
[Geneva - May 16, 2006 ]
The R&D Appeal launched in June 2005 by the Drugs for Neglected Diseases initiative (DNDi), its founding partners, Oxfam, and the BIOS initiative, urges governments to take greater leadership in R&D on neglected diseases.

More

Greater EU Leadership Needed to Further Critical Research on Neglected Diseases
[ Geneva, Switzerland - February 8, 2006 ]
At a public hearing held today at the European Parliament in Brussels, EU governments were called upon to ensure that public funding in research be primarily invested in meeting public needs and priorities, including specific health needs of populations in developing countries.

More

Experts across Asia meet to discuss a new, soon to be available, fixed-dose malaria treatment
[ Bangkok - February 2nd, 2006 ]
One of the first medicines developed by Drugs for Neglected Diseases Initiative (DNDi), fixed-dose artesunate-mefloquine will be easier to use and less expensive than current ACTs, but experts agree that action is needed to make sure the treatments reach patients.

More

Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site
is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License